By Victor Caraballo, M.D., VP of Quality Management, Independence Blue Cross A third FDA-authorized COVID-19 vaccine The U.S. Food and Drug Administration (FDA) has officially authorized the Johnson & Johnson…
Read More
Collaboration will bring two million COVID-19 vaccines to at-risk seniors across the United States in next 100 days Independence Blue Cross (Independence) joins the White House, America’s Health Insurance Plans…
Independence Blue Cross (Independence) has announced a collaboration with Massachusetts Institute of Technology (MIT) on breakthrough developments in deep learning algorithms in health care that was published in February at…
Everyone would like the pandemic to end, but many have questions about the vaccines. Independence Blue Cross Vice President of Clinical Services Dr. Reetika Kumar reviews the facts about the…
New Blue Cross Blue Shield Association Health of America data looked at Human papillomavirus (HPV) vaccination rates over a three-year period for the commercially insured population ages 10-13. HPV is a…